These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 22534782)

  • 1. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
    Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
    J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.
    Hu Y; Gu X; Li R; Luo Q; Xu Y
    J Exp Clin Cancer Res; 2010 Nov; 29(1):154. PubMed ID: 21110852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
    Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
    Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
    Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium chloride suppresses colorectal cancer cell survival and proliferation through ROS/GSK-3β/NF-κB signaling pathway.
    Li H; Huang K; Liu X; Liu J; Lu X; Tao K; Wang G; Wang J
    Oxid Med Cell Longev; 2014; 2014():241864. PubMed ID: 25002914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells.
    Yin JQ; Wen L; Wu LC; Gao ZH; Huang G; Wang J; Zou CY; Tan PX; Yong BC; Jia Q; Shen JN
    Toxicol Lett; 2013 Apr; 218(2):129-36. PubMed ID: 23164673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
    Liao X; Zhang L; Thrasher JB; Du J; Li B
    Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
    J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
    Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
    Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
    Steinbrecher KA; Wilson W; Cogswell PC; Baldwin AS
    Mol Cell Biol; 2005 Oct; 25(19):8444-55. PubMed ID: 16166627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
    Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades.
    Wang MJ; Huang HY; Chen WF; Chang HF; Kuo JS
    J Neuroinflammation; 2010 Dec; 7():99. PubMed ID: 21194439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
    Xia Y; Rao J; Yao A; Zhang F; Li G; Wang X; Lu L
    Eur J Pharmacol; 2012 Dec; 697(1-3):117-25. PubMed ID: 23051669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
    Kwon O; Kim KA; He L; Kim SO; Kim MS; Cha EY; Yoon BD; Sok DE; Jung M; Ahn JS; Kim BY
    Cell Signal; 2008 Apr; 20(4):602-12. PubMed ID: 18243662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
    Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
    Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
    Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
    Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
    Mamaghani S; Patel S; Hedley DW
    BMC Cancer; 2009 Apr; 9():132. PubMed ID: 19405981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
    Wilson W; Baldwin AS
    Cancer Res; 2008 Oct; 68(19):8156-63. PubMed ID: 18829575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.